Creation of Inceptua Clinical Trial Services Marks New Era for the Company

Luxembourg (ots/PRNewswire) -

Inceptua Group (previously Multipharma) today announces that its
Clinical Trial Supplies business unit is rebranding to Inceptua
Clinical Trial Services. Going forward, all of the group's three
business units including Clinical Trial Services, Medicines Access
and Commercial Products will be marketed under the same corporate
brand name, Inceptua.

Since the founding in 1997, Inceptua Group - headquartered in
Luxembourg - has grown to become one of the leading global players in
the clinical trial services market, offering reliable sourcing and
logistics expertise for comparator drugs, clinical trial supplies,
and clinical manufacturing services.

"The name change marks the shift from Multipharma to Inceptua and
a new era for the company. We have a strong heritage sourcing
medicine supplies for clinical trials, and we will continue to
strategically develop our offering in this niche and operate as
recognized experts in this area," says Alan Raffensperger, Chief
Executive Officer, Inceptua Group.

"At the same time the change reflects that Inceptua as a group is
further developing our position as a strategic partner for pharma
and biotech companies, advising our clients on strategies and
supporting them with solutions and services across the entire value
chain - clinical trials, medicines access and commercialization of
products. As of today, our new trademark Inceptua allows us to
market our combined offer to clients under the same brand name,
reflecting our strategy to be a trusted partner covering the value
chain from trial to commercialization."

As of 2018, the company is operating from offices in Luxembourg,
Germany, Switzerland, Japan, the US, the UK, Sweden and China.
Inceptua's multinational team has a global network as well as people
on the ground with local knowledge and expertise. This extensive
network of global connections means that while the majority of
purchasing is direct from manufacturers, the group also has access to
qualified distributors to meet customer needs, as well as critical
understanding of local and regional regulatory and compliance
requirements.

Looking ahead, Inceptua Group has a clear ambition to grow even
further and to help solve complex, medical challenges globally:

"Our aim is to further realize the potential of our position as a
trusted partner for our clients, by understanding their needs and
delivering value in a long-term strategic partnership, both within
clinical trial services as well as in our other business areas,
medicines access, and commercial products and services. We offer a
personalized approach and aim to provide our customers and clients
with solutions that positively impact patients' lives worldwide,"
says Kay-Christian Karstadt, Chief Operating Officer.

"We have seen a rapid, increasing and significant development of
growth in the need for clinical trial services to meet today's
healthcare burden in areas of high unmet medical need. It is our
strategy with Inceptua Clinical Trial Services to navigate the
complex and highly dynamic environment, providing a vital advisory
role for customers and supporting them throughout the process."

About Inceptua Clinical Trial Services

Inceptua Clinical Trial Services offers a range of solutions,
including strategic planning, clinical trial supply sourcing,
clinical manufacturing, and end-to-end depot and distribution
management to ensure the precise requirements of your trial are met.

The team has a thorough understanding of customers' requirements
during the procurement process, whether they require commercial drugs
for comparator trials or innovator products for biosimilar
development.

Inceptua Clinical Trial Services is a business unit of Inceptua, a
specialist multinational company headquartered in Luxembourg that has
been providing unlicensed medicines for named patient programs since
1997, and medicine supplies for clinical trials since 2004. For more
information, please visit our website at http://www.inceptua.com.

About Inceptua

The Inceptua Group is a global, dynamic and future-oriented
service provider and partner for the pharmaceutical and biotech
industry, providing critical treatments to patients in need. Inceptua
has global operations within clinical trial supply chain and
manufacturing, medicine access and unlicensed medicines, as well as
commercial products and services.

ots Originaltext: Inceptua
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Nicola Lilley
Account Director
Havas SO
[e-mail]
[phone]. Miranda McLaughlan
Corporate Communications Manager
Inceptua
[e-mail]
[phone]